Giuseppe
Emeritus
[Source: BMC Medicine, full page: (LINK). Abstract, edited.]
------
Review
New treatments for influenza
Sailen Barik
Correspondence: Sailen Barik s.barik@csuohio.edu
BMC Medicine 2012, 10:104 doi:10.1186/1741-7015-10-104
Published: 13 September 2012
Abstract (provisional)
Influenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics. The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomic segments, promote antigenic diversity and new subtypes, allowing the virus to evade vaccines and become resistant to antiviral drugs. There is thus a continuing need for new anti-influenza therapy using novel targets and creative strategies. In this review, we summarize prospective future therapeutic regimens based on recent molecular and genomic discoveries.
-New treatments for influenza
Sailen Barik
Correspondence: Sailen Barik s.barik@csuohio.edu
BMC Medicine 2012, 10:104 doi:10.1186/1741-7015-10-104
Published: 13 September 2012
Abstract (provisional)
Influenza has a long history of causing morbidity and mortality in the human population through routine seasonal spread and global pandemics. The high mutation rate of the RNA genome of the influenza virus, combined with assortment of its multiple genomic segments, promote antigenic diversity and new subtypes, allowing the virus to evade vaccines and become resistant to antiviral drugs. There is thus a continuing need for new anti-influenza therapy using novel targets and creative strategies. In this review, we summarize prospective future therapeutic regimens based on recent molecular and genomic discoveries.
------